U.S. Beverage Stock News

If you are wondering whether Bel Fuse shares still offer value after a strong run, this article explains what the current price might be implying about the business. The stock closed at US$172.94 recently, with a 7 day return of an 18.4% decline and a 30 day return of a 16.0% decline, while the 1 year return sits at 119.7% and the 3 year return is very large. These price moves sit against a backdrop of ongoing attention on Bel Fuse within the tech sector, as investors reassess companies that...

If you are wondering whether Microsoft is still fairly priced after its long run as a market heavyweight, looking closely at its current valuation can help you decide how it might fit into your portfolio. The stock last closed at US$408.96, with returns of 2.6% over the past 7 days, 1.9% over the past 30 days, a year-to-date return of a 13.5% decline, and 8.4% over the past year. The 3-year and 5-year returns sit at 64.9% and 81.5% respectively. Recent headlines around Microsoft have focused...

On February 24, 2026, Brady Corporation’s board declared a US$0.245 per-share dividend on Class A common stock, payable April 30, 2026, to shareholders of record as of April 9, 2026. This dividend decision comes alongside multi-year growth in sales, earnings, and free cash flow, underscoring Brady’s capacity to return cash to investors. We’ll now examine how Brady’s dividend declaration, against a backdrop of solid multi-year earnings and cash flow growth, influences its investment...

In a recent filing, Eva Live announced it secured $7 million in growth financing, another step closer to advancing the company’s broader investment narrative.

Recent share performance and business snapshot With no single headline event driving attention to Veris Residential (VRE), the recent share performance itself is the focus, as the stock shows double digit returns over the past month and past 3 months. Veris Residential is a real estate investment trust focused on Class A multifamily properties in the Northeast. It uses a technology enabled, vertically integrated platform to manage, operate, acquire, and develop its portfolio for residents and...

Certara recently highlighted that its Simcyp physiologically-based pharmacokinetic modeling was accepted by the U.S. FDA in place of multiple clinical pharmacology studies to support the new drug application for asciminib (Scemblix®), an allosteric BCR::ABL1 inhibitor for Chronic Myeloid Leukemia. This decade-long modeling effort, which replaced at least ten dedicated clinical studies and informed dosing and drug-interaction decisions, underscores how biosimulation can cut development costs...

MarketAxess Holdings Inc. recently appointed William Quan as Chief Technology Officer, tasking him with modernizing its global technology platforms and embedding AI and advanced data capabilities across the business. By bringing in a leader with deep experience in electronic trading and AI-driven platforms from firms like Amazon Web Services, J.P. Morgan, and Deutsche Bank, MarketAxess is signaling a stronger push to enhance its bond-trading technology and product innovation. With William...

In recent days, investor concerns about regional banks’ exposure to the opaque private credit market have weighed on The Bancorp, amid broader sector jitters following defaults and loan write-offs in that space. These worries come on top of earlier pressure from weaker quarterly results and a shrinking net interest margin, even as The Bancorp has built a niche in specialized fintech-focused banking and lending solutions. Next, we’ll examine how heightened worries about private credit...

In February 2026, Xylem Inc. announced that its Board of Directors had approved a new share repurchase program, authorizing the company to buy back up to US$1.50 billion of its own stock with no expiration date. This move follows the completion of a prior authorization under which Xylem repurchased 5,200,000 shares for US$321.90 million, highlighting an ongoing preference for returning capital to shareholders alongside reinvestment in the business. We’ll now explore how this sizable,...

In late February 2026, SS&C Technologies Holdings, Inc. reported an 8.1% year-on-year revenue increase that exceeded analyst expectations and raised its full-year EPS and revenue guidance, citing strong execution and the breadth of its software and services portfolio. A few days earlier, SS&C announced a generative AI-powered sales enablement solution developed with Thornburg Investment Management, embedding advisor insights directly into CRM systems to streamline how asset managers prepare...

Why Brixmor Property Group Stock Is On Investors’ Radar Brixmor Property Group (BRX) has drawn fresh attention after recent trading left the stock with a month return of 6.2% and a past 3 months move of 21.9%, prompting closer scrutiny of the REIT’s fundamentals. See our latest analysis for Brixmor Property Group. At a share price of US$30.07, Brixmor’s recent 6.2% 1 month and 21.9% 3 month share price returns contrast with some softer short term moves. Its 1 year and multi year total...

DT Midstream (DTM) has drawn fresh attention after reporting 17% year-over-year adjusted EBITDA growth for 2025, expanding its Pipeline segment to 70% of the business and raising its quarterly dividend by 7.3%. See our latest analysis for DT Midstream. The latest operational update seems to line up with recent market interest, with a 30 day share price return of 10.1% and a 90 day share price return of 17.5%. The 1 year total shareholder return of 65.6% and 3 year total shareholder return of...

In early March 2026, SES AI Corporation reported full-year 2025 results showing sales of US$21.00 million, a smaller net loss of US$73.04 million, a Q4 revenue shortfall versus expectations, and new 2026 revenue guidance of US$30.00 million to US$35.00 million alongside a projected reset in gross margins. The earnings release also revealed a pivot away from automotive battery mass production toward energy storage systems, drones, and materials, while logistics-driven shipment delays and...

Vulcan Materials (NYSE:VMC) reported quarterly results that came in below expectations, alongside softer guidance for the near term. J.P. Morgan downgraded the stock and flagged the possibility that demand growth could stay subdued until 2027. Short interest in Vulcan Materials has risen, pointing to increased bearish positioning in the shares. Vulcan Materials, trading at $274.99, is coming off a tough stretch, with the stock down 11.3% over the past week and 15.1% over the past month...

In recent days, Commerce Bancshares (NASDAQ: CBSH) has come into focus after an analyst rating upgrade and shifts in institutional portfolios around the regional bank. This attention, framed by comparisons to trends linked to the Nasdaq 100 index, has intensified discussion of how Commerce Bancshares fits into broader banking exposure. We will now examine how the recent analyst upgrade, alongside institutional portfolio changes, could shape Commerce Bancshares’ evolving investment...

In early March 2026, Alto Ingredients reported fourth-quarter 2025 sales of US$231.97 million and net income of US$21.81 million, marking a shift from a loss a year earlier and delivering positive earnings per share for both the quarter and full year. This earnings release highlighted how portfolio realignment, improved crush margins, higher-value renewable fuel exports, and benefits from the 45Z clean fuel production credit collectively turned prior losses into profit across Alto’s...

United States Lime & Minerals (USLM) jumped 9.9% after the February ISM Manufacturing report highlighted rising input prices, which investors interpreted as potential pricing power and margin support for industrial suppliers. See our latest analysis for United States Lime & Minerals. That ISM driven jump comes on top of a 1 year total shareholder return of 30.39% and a very large 3 year total shareholder return of 294.55%, even though the year to date share price return is slightly negative...

Douglas Dynamics, Inc. has already reported fourth-quarter 2025 results, with sales rising to US$184.54 million and net income reaching US$12.84 million, alongside full-year 2025 sales of US$656.05 million and a quarterly dividend of US$0.295 per share declared for payment on March 31, 2026. Management’s 2026 net sales outlook of US$710 million to US$760 million, combined with higher quarterly earnings versus the prior year, has prompted analysts to reassess how earnings quality, demand...

Why Stepan’s latest earnings matter for shareholders Stepan (SCL) just released fourth quarter and full year 2025 results, pairing higher quarterly sales and net income with a goodwill impairment charge and a reaffirmed quarterly cash dividend of $0.395 per share. This mix of earnings, impairment and dividend news gives you a fresh look at how the chemical producer is balancing reported profitability, balance sheet adjustments and ongoing cash returns to shareholders. See our latest analysis...

In late February and early March 2026, analysts including Citi, Raymond James, and Barclays turned more cautious on American Homes 4 Rent, citing softer rental demand, elevated new supply, and rising concessions across single-family and multifamily markets. At Citi’s Miami Global Property CEO Conference 2026, American Homes 4 Rent outlined its response with a new US$500 million share repurchase authorization and plans to develop about 1,900 homes in 2026 while closely tracking legislative...

Quarterly earnings and dividend catch investors’ attention Smith & Wesson Brands (SWBI) recently reported third quarter results alongside a fresh dividend announcement. This gives investors new data on both operating performance and direct cash returns. For the quarter ended January 31, 2026, sales were US$135.71 million compared with US$115.89 million a year earlier, while net income was US$3.75 million versus US$2.10 million. See our latest analysis for Smith & Wesson Brands. The earnings...

Nurix Therapeutics recently amended its equity distribution agreement to allow sales of up to US$413.65 million of common stock through Piper Sandler under its existing shelf registration. This expanded at-the-market facility gives Nurix added funding flexibility, potentially affecting how investors assess its balance between capital needs and ownership dilution. We will now examine how this enlarged at-the-market capacity shapes Nurix’s investment narrative, particularly around funding...

What triggered the latest move in Distribution Solutions Group? Distribution Solutions Group (DSGR) is back in focus after its fourth quarter and full year 2025 earnings missed analyst expectations on both revenue and earnings, pressuring margins and sparking legal scrutiny following a sharp share price reaction. See our latest analysis for Distribution Solutions Group. The sharp post earnings drop has fed into a wider reset in expectations, with a 7 day share price return of 26.12% and a...

In early March 2026, Mobix Labs, Inc. reported new production purchase orders for its high-reliability electromagnetic interference protection components used in Gulfstream business jets and the U.S. Navy’s Tomahawk cruise missile program, alongside a change to its bylaws reducing the shareholder meeting quorum requirement to one-third of voting power. The fresh aerospace and defense orders underline Mobix Labs’ role as an already-qualified supplier embedded in mission-critical platforms...